A 6-month Mobile Health (mHealth) intervention significantly improved systolic blood pressure decrease (p=0.01) and BP monitoring adherence compared with standard follow-up.
RCT (n=30)
Randomly assigned
Does a Mobile Health (mHealth) intervention improve blood pressure and adherence in patients with hypertension in an underserved urban community?
A 6-month mHealth intervention significantly improved systolic blood pressure and medication adherence self-efficacy in an underserved urban community.
p-value: p=0.01
This 6-month pilot randomized controlled trial examined the effectiveness of a Mobile Health (mHealth) intervention for hypertension self-monitoring and management in an underserved urban community. The four health outcomes measured included changes in systolic and diastolic blood pressure (BP), BP monitoring adherence, perceived medication adherence self-efficacy, and health-related quality of life. Thirty participants were randomly assigned to the mHealth group or a standard follow-up group; 25 participants completed the study. The mHealth group had statistically significant improvement in systolic BP decrease ( p = .01). The mHealth group had better adherence to BP monitoring and improved perceived medication adherence self-efficacy at 6 months, compared with the standard follow-up group. The results suggest that an mHealth intervention has the potential to facilitate hypertension management in underserved urban communities.
Zha et al. (Sun,) conducted a rct in Hypertension (n=30). Mobile Health (mHealth) intervention vs. Standard follow-up was evaluated on Changes in systolic and diastolic blood pressure, BP monitoring adherence, perceived medication adherence self-efficacy, and health-related quality of life (p=0.01). A 6-month Mobile Health (mHealth) intervention significantly improved systolic blood pressure decrease (p=0.01) and BP monitoring adherence compared with standard follow-up.